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Isolation of equine herpesvirus-2 from the lung of an aborted fetus
Cecilia Monica Galosi1, Viviana Cid de la Paz, Leandro Carlos Fernández, Javier Pablo Martinez, 
Maria Isabel Craig, Maria Barrandeguy, Maria Elisa Etcheverrigaray
Abstract. This study describes the isolation of equine herpesvirus-2 (EHV-2) from the lung of an aborted 
equine fetus in Argentina. The isolated virus was confirmed as EHV-2 by indirect immunofluorescence using 
a rabbit anti-EHV-2 polyclonal antiserum and by virus-neutralization test using an equine polyclonal antibody 
against EHV-2. Restriction endonuclease DNA fingerprinting with BíwhHI also confirmed the identity of the 
virus as EHV-2. Furthermore, viral nucleic acid was detected by polymerase chain reaction from the original 
lung sample and from the DNA obtained from cells infected with the virus isolate. This work constitutes the 
first reported isolation of EHV-2 from an aborted equine fetus. The presence of EHV-2 in the lung of the aborted 
fetus would indicate that this virus is capable of crossing the placental barrier. However, no cause-effect 
relationship was established between the EHV-2 isolate and the abortion.
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The horse is the natural host for 5 recognized herpesvi­
ruses: equine herpesviruses 1, 3, and 4 (EHV-1, EHV-3, and 
EHV-4) belong to the Alphaherpesvirinae subfamily, where­
as EHV-2 and EHV-5 are classified within the Gammaher- 
pesvirinae subfamily. 18’20’21 Tfie EHV-1 and EHV-4 are major 
causes of abortion and respiratory disease, respectively, and 
they are of considerable economic importance worldwide. 
Equine herpesvirus-3 (equine coital exanthema virus) is the 
causative agent of a relatively mild genital exanthema of 
both mares and stallions. In Argentina, EHV-1 and EHV-4 
have been isolated from aborted fetuses, stillborn foals, and 
horses, with respiratory disease. The EHV-3 was isolated for 
the first time in Argentina from thoroughbred horses in train­
ing, suffering from unilateral rhinitis.2’8’11
The EHV-2 infection occurs soon after birth, often in the 
presence of maternal antibodies.16 The prototype strain of 
EHV-2 (LKV), the first gammaherpesvirus recovered from 
the horse, was isolated in 1962 from the respiratory tract of 
a foal with “catarrh and coughing.”3 The virus has been 
isolated from leukocytes and various organs of healthy ani­
mals or horses with upper respiratory disease signs, anorex­
ia, serous nasal discharge, conjunctivitis, fever and pneu­
monia, general malaise, and poor performance.4-7 Equine 
herpesvirus-2 may play a role as a predisposing factor for 
other infections such as Rhodococcus equi infection.14 The 
virus can establish either a persistent or a latent infection in 
B lymphocytes and has been isolated from peripheral mono­
nuclear cells and mammary gland macrophages.10’12’14’17 It
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has also been suggested that EHV-2 may play a role in trans­
activation and reactivation of latent EHV-1 and EHV-4 in­
fections.9 Prenatal infection with EHV-2 has not been re­
corded, and the virus has not been detected in colostrum or 
milk. There is no evidence that EHV-2 has abortigenic po­
tential. Experimental infection of a mid-gestational equine 
fetus in utero resulted in normal term delivery, although the 
foal showed mild rhinitis and conjunctivitis, with nasal shed­
ding of EHV-2.13’19
Similar to EHV-2, EHV-5 infection has been associated 
with upper respiratory disease, and the 2 viruses can simul­
taneously coinfect the same individual. Both the viruses are 
slow growing in primary isolation; they remain highly cell 
associated and cannot be differentiated by their growth prop­
erties in cell culture.9
A high prevalence of neutralizing antibodies against EHV- 
2 (up to 90%) has been reported in horses worldwide, and 
the virus has been isolated from circulating leukocytes in 
89% of adult horses in the United States, 86% in Scotland, 
90% in England, 55% in Japan, and 77% in Switzerland.3 In 
Australia and the UK, 97% of examined abattoir horses har­
bored the virus in their lymphoid cells.15. In Argentina, the 
serological prevalence is 80%, and the virus has been iso­
lated from animals with respiratory disease and detected by 
polymerase chain reaction (PCR) from nasal swab samples 
(Craig, unpublished data).
This study describes the isolation of EHV-2 from the lung 
of an aborted fetus. Pieces of lung, liver, and spleen were 
collected at necropsy from an aborted fetus submitted from 
a farm located in the Province of Buenos Aires. The samples 
were investigated for the presence of infectious virus by in­
oculation of supernatant into rabbit kidney (RK13) cells, and 
cytopathic effects (CPE) were monitored. On day 17 after 
inoculation, new cultures were established with the infected 
cells and by addition of fresh cells. Blood from the aborting 
mare was collected on the day of abortion and 20 days after 
abortion, and sera were prepared for use in virus-neutrali­
zation (VN) assays. The VN titers were determined by stan­
dard technique against 100 tissue culture infective doses 
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50% (TCID50%) of the first EHV-2 strain isolated in Ar­
gentina (Craig, unpublished data). To confirm the isolate as 
EHV-2, VN test were performed using an equine polyclonal 
antibody against EHV-2 and polyclonal antibodies against 
EHV-1, EHV-4, and equine arteritis virus (Bucyrus strain)3 
as controls. In addition, standard immunofluorescence (IF) 
test was prepared using a rabbit anti-EHV-2 polyclonal 
antiserumb and fluorescein isothiocyanate-labeled anti-rabbit 
immunoglobulin G antibody.3
The restriction endonuclease (RE) analysis was done as 
described by Galosi et al.11 The RK13-infected cells were 
treated with proteinase K,d and total DNA was extracted with 
phenol and phenol-chloroform-isoamylalcohol, precipitated 
with cold absolute alcohol and finally cleaved with .B«wHI.d 
The resultant restriction pattern obtained by agarose gel elec­
trophoresis was compared with patterns from 2 reference 
articles.1’7 To detect EHV-2 DNA, a previously described 
nested PCR was used to amplify a region located upstream 
of the gene that encodes a product homologous to human 
interleukin-10.4
A virus confirmed to be EHV-2 was isolated from RK13 
cells inoculated with the lung sample from the aborted 
equine fetus. The CPE consisted of foci of rounded cells and 
were detected about 14 days after inoculation of RK13 cell 
monolayers, with a 1:10 dilution of the processed lung sam­
ple. In newly established, infected cell monolayers, cyto- 
pathic changes developed slowly as has been described for 
EHV-2 by other authors.7 Complete CPE was not detected 
even after 7-10 days of incubation. The EHV-2-positive 
cells were demonstrated by immunofluorescent staining. No 
viral CPE or virus-specific fluorescence was observed on 
RK13 cells inoculated with liver and spleen samples from 
the aborted fetus or in mock-infected cells. The EHV-2 VN 
titers detected on both serum samples obtained from the 
aborting mare were high (1:512). Identity of the isolated vi­
rus (designated BB03) was confirmed by VN assay with a 
polyclonal antibody against EHV-2. The virus was not neu­
tralized by antisera against EHV-1, EHV-4, or equine arter­
itis virus. The RE analysis with /LwN II confirmed that the 
virus was EHV-2.1’7 The second round of nested PCR using 
EHV-2-specific primers and DNA extracted from the lung 
sample or from infected cells amplified a visible product of 
the expected size (~750 bp).4 The PCR assay was negative 
for DNA extracted from liver and spleen samples and for 
EHV-1 DNA used as a negative control.
The EHV-2 was first isolated in Argentina from equine 
nasal swabs in 1997. The EHV-2 has been detected in var­
ious regions of the world; however, the exact prevalence and 
pathogenic role of this gammaherpesvirus are still not clear.17 
In this study, the authors isolated EHV-2 from the lung of 
an equine aborted fetus. A long period of time (14 days) was 
required for the virus to replicate and produce CPE in cell 
culture. The high titer of neutralizing antibodies against 
EHV-2 present in the mare could indicate a recent exposure 
to the virus. There is no evidence to indicate that EHV-2 has 
abortigenic potential and the virus is not known to be trans­
mitted from mare to foal via vaginal secretions and colos­
trum.14’19 Experimentally, it has been found that a pregnant 
mare inoculated with EHV-2 by the intrauterine route did 
not have any effect on the pregnancy; however, the normal 
newborn foal showed signs of disease at 4 days after birth.13 
Although vertical transmission of EHV-2 has not been dem­
onstrated, it is recognized that the role of the mare in trans­
mitting EHV-2 infections requires further investigation.6 Vi­
ral persistence and latency are features of all herpesviruses. 
The EHV-2 is similar to Epstein Barr virus in that persis­
tence and latency occur within peripheral blood mononuclear 
cells.4 Some authors suggest that although EHV-2 infection 
is very common, the mechanism and location of persistence 
of the virus is not well known.17 The authors of this study 
propose that the EHV-2 isolate in this study was present in 
the mare’s leukocytes and was carried across the placenta to 
the fetus. Equine herpesvirus-2 is reported to belong to a 
heterogeneous group of viruses, and the characteristics of 
different strains are likely to vary and could reflect biolog­
ical differences.4’6’7 This work constitutes the first reported 
isolation of EHV-2 from an aborted equine fetus. The pres­
ence of EHV-2 in the lung of the aborted fetus would indi­
cate that this virus crossed the placental barrier. However, it 
is not known whether EHV-2 was responsible for this abor­
tion. Nevertheless, the finding of possible transplacental 
transmission of EHV-2 is a novel observation that should be 
taken into account in future studies on EHV-2.
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Erratum
J Vet Diagn Invest 17:58—61 (2005)
The PCR primers listed in the article entitled, "Diagnostics of Infectious Canine Hepatitis Virus (CAV-1) 
Infection in Puppies with Encephalopathy” (J Vet Diagn Invest 17:58-61 (2005)) were incorrect. The correct 
primers as listed in the source reference for the article should be:
5'-GCCGCA (G/A) TGGT C(T/C) TACATGCAC ATC-3'
5'-CAGC(A/G) (C/T) (G/A) CCGCGGATGTCAAA (G/A) T-3'
The authors and Editor regret any confusion caused by publication of incorrect primer sequences.
J Vet Diagn Invest 17:502 (2005)
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